Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Contraception - Management
How does the presence of, or increased risk for, a sexually transmitted infection or pelvic inflammatory disease influence choice?

  • Women with a history of pelvic inflammatory disease and with no current risk factors for sexually transmitted infection (STI)
      • All methods can be used without restriction.
  • Women with current pelvic inflammatory disease
    • Copper IUDs and the levonorgestrel-releasing IUS should not be inserted. However, there is generally no need for removal if the woman wishes to continue their use.
    • All other methods can be used without restriction.
  • Women with a current STI
    • Chlamydia, or purulent cervicitis or gonorrhoea infection:
      • Copper IUDs and the levonorgestrel-releasing IUS should not be inserted. However, there is generally no need for removal if the woman wishes to continue their use.
      • All other methods can be used without restriction.
    • Vaginitis, other STIs (excluding HIV and hepatitis), and increased risk of STIs:
      • Copper IUDs and the levonorgestrel-releasing IUS can generally be used (advantages generally outweigh the risks).
      • All other methods can be used without restriction.
Clarification / Additional information
Basis for recommendation
  • These recommendations are based on guidelines published by the Faculty of Sexual and Reproductive Health Care (FSRHC), formerly the Faculty of Family Planning and Reproductive Health Care (FFPRHC) [FSRH, 2009b].

© NHS Institute for Innovation and Improvement